U.S. Insurance Stock News

NYSE:HAE
NYSE:HAEMedical Equipment

Haemonetics Wins FDA Nod For Persona PLUS Plasma Growth Opportunity

Haemonetics (NYSE:HAE) has received FDA 510(k) clearance for its NexSys PCS Plasma Collection System with Persona PLUS technology. The clearance covers the company's next generation plasma collection platform, Persona PLUS, which is designed to improve plasma collection per donation. This regulatory milestone marks an important step in advancing Haemonetics' plasma collection offerings within the U.S. market. Haemonetics focuses on blood and plasma collection technologies, so any regulatory...
NYSE:WAT
NYSE:WATLife Sciences

Slowing Growth Concerns Around Waters’ ESOP Shelf Registration Might Change The Case For Investing In WAT

Waters Corporation recently filed a US$116.67 million shelf registration for 350,000 common shares tied to an employee stock ownership plan and earlier this month presented at TD Cowen’s 46th Annual Health Care Conference in Boston, led by President and CEO Udit Batra. These developments come as investors weigh concerns about Waters’ slowing 2.1% organic revenue growth, shrinking adjusted operating margins, and a weaker return on invested capital over the past two years. We’ll now examine...
NYSE:KMPR
NYSE:KMPRInsurance

Kemper’s Q4 Miss and Strategy Shift Could Be A Game Changer For Kemper (KMPR)

Kemper Corporation recently reported a past fourth quarter with a 4.3% year-on-year revenue decline, missing analyst forecasts for both revenue and net premiums earned, while Interim CEO C. Thomas Evans, Jr. said the company is taking deliberate actions to address these performance issues. This weak quarter left Kemper lagging peers on growth and estimate accuracy, raising fresh questions about the resilience of its business fundamentals and execution. Next, we'll examine how Kemper's missed...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

Assessing CRISPR Therapeutics (CRSP) Valuation As Casgevy Expectations and Forecast Revisions Draw Investor Focus

CRISPR Therapeutics (CRSP) has been back in focus after a series of reports highlighted strong investor interest, tied to expectations for higher revenue from its Casgevy gene therapy, even as the company continues to report losses. See our latest analysis for CRISPR Therapeutics. The recent 16.9% 1 month share price return and 11.6% year to date share price return to around $60 suggest momentum has picked up again. The 1 year total shareholder return of 36.9% contrasts with a weaker 5 year...
NYSE:HOG
NYSE:HOGAuto

Harley-Davidson (HOG) Valuation Reassessed As Slower Product Uptake And Higher Investment Plans Raise Profitability Questions

Conference appearance comes as investors reassess Harley-Davidson Harley-Davidson (HOG) is set to appear at Citi's 2026 Global Consumer & Retail Conference just as investors are weighing slower product uptake, planned higher investment spending, and an expected 4.4 percentage point drop in free cash flow margin. See our latest analysis for Harley-Davidson. The latest 5.3% 1 day share price return and 4.2% 7 day share price return to US$19.46 only partly offset a 90 day share price return...
NYSE:ZIM
NYSE:ZIMShipping

Regulatory Tests Put ZIM Hapag Lloyd Deal And Investor Expectations In Focus

Hapag-Lloyd has signed an agreement to acquire ZIM Integrated Shipping Services (NYSE:ZIM). The transaction is subject to regulatory reviews in multiple jurisdictions. Israel's government, which holds a golden share in ZIM, is expected to play a key role in the approval process. Industry attention is now on how the merger terms and approvals could affect ZIM's future operations and ownership structure. ZIM Integrated Shipping Services operates as a global container liner company, with a...
NYSE:HY
NYSE:HYMachinery

Hyster‑Yale (HY) TTM Losses Challenge Long‑Term Margin Expansion Narratives

Hyster-Yale (HY) closed out FY 2025 with Q4 revenue of US$923.2 million and a basic EPS loss of US$2.96, as net income excluding extra items came in at a loss of US$52.5 million. Over the last six reported quarters, revenue has moved between US$910.4 million and US$1,067.5 million, while quarterly basic EPS has ranged from a profit of US$0.98 to a loss of US$2.96. This underscores how sensitive earnings have been around relatively stable top line levels. For investors, the latest numbers put...
NasdaqGM:EML
NasdaqGM:EMLMachinery

Eastern (EML) Margin Compression To 2.4% Challenges Bullish Profitability Narratives

Eastern (EML) has wrapped up FY 2025 with fourth quarter revenue of US$57.5 million and basic EPS of US$0.20, alongside net income from continuing operations of roughly US$1.2 million. Over the past few quarters, the company has seen revenue move from US$71.3 million in Q3 FY 2024 to US$66.7 million in Q4 FY 2024, then to US$65.9 million, US$70.2 million, US$55.3 million and finally US$57.5 million across FY 2025. Quarterly EPS has shifted from US$0.75 to US$0.25 and then between US$0.35 and...
NYSE:CRM
NYSE:CRMSoftware

Does Salesforce’s F1 AI Fan Agent Showcase a Durable Agentforce Advantage for CRM?

In early March 2026, Salesforce and Formula 1 launched an Agentforce-powered fan companion agent on F1.com to provide F1’s 827 million fans with 24/7, AI-driven explanations of the complex 2026 regulations and personalized insights based on trusted F1 data sources. This launch showcases Salesforce’s Agentforce 360 platform as a real-world example of AI agents augmenting human support at global scale, highlighting how digital labor can deepen engagement while freeing staff to focus on...
NYSE:ACA
NYSE:ACAConstruction

Is Arcosa (ACA) Quietly Redrawing Its Infrastructure Playbook With New Guidance And A Barge Exit?

In late February 2026, Arcosa, Inc. reported past fourth-quarter 2025 sales of US$716.7 million and net income of US$52.1 million, issued 2026 guidance calling for higher full-year revenues and net income, affirmed its regular US$0.05 quarterly dividend, and agreed to sell its barge business for US$450 million in cash. Together, these updates show Arcosa sharpening its focus on construction materials and engineered structures while using barge-sale proceeds and stronger earnings to support...
NYSE:NOW
NYSE:NOWSoftware

Why ServiceNow (NOW) Is Up 9.2% After Expanding Its AI Workflow “Control Tower” Platform

In late February and early March 2026, ServiceNow expanded its AI platform with the launch of Autonomous Workforce and EmployeeWorks, new telecom roaming and security integrations, and FedRAMP Authorization for Moveworks, while also filing employee stock plan-related shelf registrations totaling about US$102.91 million in common stock. Together, these moves deepen ServiceNow’s role as an AI workflow “control tower” across IT, telecom, security, and the public sector, reinforcing its...
NasdaqGM:NPCE
NasdaqGM:NPCEMedical Equipment

NeuroPace (NPCE) Loss Narrowing In Q4 Tests Bullish Profitability Narrative

NeuroPace (NPCE) has just closed out FY 2025 with Q4 revenue of US$26.6 million and a basic EPS loss of US$0.08, while trailing twelve month figures show revenue of US$100.0 million and a basic EPS loss of US$0.66 as the company continues to operate at a loss. Over the past several quarters, the business has seen revenue move from US$21.5 million in Q4 2024 to US$26.6 million in Q4 2025, with quarterly basic EPS losses ranging between US$0.18 and US$0.26 before the latest US$0.08 print. This...
NasdaqCM:REAX
NasdaqCM:REAXReal Estate

Real Brokerage (REAX) Nears Breakeven In Q3 Which Tests Bears On Profitability Timeline

Real Brokerage (NasdaqCM:REAX) has just posted its FY 2025 third quarter scorecard, with revenue of US$568.5 million and a small net loss of US$0.4 million translating to basic EPS of US$0.00. Trailing 12 month revenue sits at about US$1.8 billion alongside a net loss of US$10.5 million and basic EPS of US$0.05. Those figures come at a time when investors are weighing ongoing losses against forecasts for faster growth and a path to profitability, putting the focus firmly on how margins evolve...
NYSE:O
NYSE:ORetail REITs

Does Realty Income’s (O) Guidance Cut and Leadership Change Hint at a Shifting Income Strategy?

In late February 2026, Realty Income reported higher quarterly and full-year 2025 revenue and net income, issued 2026 earnings guidance of US$1.65–US$1.69 per share, and subsequently saw its stock rating cut to Hold from Buy by Freedom Capital Markets. Shortly after these updates, Realty Income also announced the planned departure of its Chief Legal Officer, underscoring both leadership transition and investor focus on how management will execute against modest 2026 guidance. We’ll now...
NYSE:TREX
NYSE:TREXBuilding

Assessing Trex Company (TREX) Valuation After Mixed Share Performance And Modest Undervaluation Estimate

What recent performance says about Trex Company (TREX) With no single headline event driving Trex Company (TREX) today, the stock’s recent performance is doing most of the talking for investors tracking entry or exit points. Over the past month the share price shows a return of about a 3% decline, while the past 3 months reflect a gain of roughly 17%. On a 1 year view, the stock is down around 31%, and longer 3 year and 5 year total returns are also negative. That mixed record contrasts with...
NYSE:EPRT
NYSE:EPRTREITs

Is Essential Properties Realty Trust (EPRT) Still Attractive After Recent Share Price Gains

If you are wondering whether Essential Properties Realty Trust is reasonably priced or starting to look expensive, you are not alone. The stock last closed at US$34.57, with returns of 3.4% over 7 days, 14.8% over 30 days, 15.0% year to date and 12.0% over the past year, which naturally raises questions about what is already reflected in the price. Recent attention on Essential Properties Realty Trust has largely focused on its role as a net lease REIT and how that business model fits into...
NYSE:WCC
NYSE:WCCTrade Distributors

Is It Too Late To Consider WESCO International (WCC) After Its 69% One Year Rally?

If you are wondering whether WESCO International's share price still reflects fair value after a strong run, this article walks through what the numbers are actually saying about the stock. The shares last closed at US$286.58, with returns of 13.7% year to date and 69.0% over the past year, although the stock has seen short term setbacks with 7 day and 30 day returns of 3.6% and 3.8% declines respectively. Recent market interest has been shaped by ongoing coverage of WESCO International as a...
NasdaqGS:FITB
NasdaqGS:FITBBanks

A Look At Fifth Third Bancorp (FITB) Valuation As Short Interest Falls And Growth Plans Gain Support

Fifth Third Bancorp (FITB) is back on investors’ radar after a sharp 31.3% drop in short interest, a wave of upbeat analyst commentary, and fresh branch expansion plans tied to its multi year growth strategy. See our latest analysis for Fifth Third Bancorp. At a share price of US$49.54, Fifth Third has given investors a 3.8% year to date share price return, while its 1 year total shareholder return of 26.9% points to momentum that has so far outweighed the recent 1 month pullback. This...
NasdaqGS:REAL
NasdaqGS:REALSpecialty Retail

A Look At The RealReal (REAL) Valuation After Strong Q4 Results And 2026 Growth Guidance

The RealReal (REAL) just paired a strong fourth quarter with fresh 2026 guidance, reporting higher year over year revenue, narrower net losses and its first full year of consistently positive adjusted EBITDA. See our latest analysis for RealReal. After this earnings and guidance update, RealReal’s latest share price of $12.13 comes after mixed short term moves, with a 4.30% 1 day share price return but a 17.54% 30 day share price decline, while the 1 year total shareholder return of 111.88%...
NasdaqGS:HUT
NasdaqGS:HUTSoftware

Is Hut 8’s AI Data Center Pivot Amid Heavy 2025 Losses Altering The Investment Case For Hut 8 (HUT)?

In February 2026, Hut 8 Corp. reported fourth-quarter 2025 revenue of US$88.49 million, full-year 2025 revenue of US$235.12 million, and a full-year net loss of US$226.15 million, while also announcing a partnership with Anthropic and Fluidstack to build AI data center infrastructure in the United States. The combination of deep losses alongside a push into AI-focused data centers highlights Hut 8’s effort to lessen its dependence on Bitcoin-linked income and broaden its infrastructure...
NYSE:TDY
NYSE:TDYElectronic

Assessing Teledyne Technologies (TDY) Valuation After New Defense Electronics And Unmanned Drone Initiatives

Teledyne Technologies (TDY) has drawn fresh attention after unveiling a Wideband Limiter aimed at protecting radar and electronic warfare systems from high power RF and directed energy threats, alongside a new unmanned drone collaboration. See our latest analysis for Teledyne Technologies. The recent run of product launches in electronic warfare, RF components and thermal imaging, together with a credit agreement tweak, comes against a strong 30 day share price return of 11.34% and a 1 year...
NYSE:UHS
NYSE:UHSHealthcare

Assessing Universal Health Services (UHS) Valuation After Recent Share Price Weakness

Recent performance snapshot Universal Health Services (UHS) has attracted investor attention after recent share price moves, with the stock showing mixed returns over the past week, month and past 3 months. Over the past day, the share price return was about 1.2% lower, while the past week shows a decline of roughly 12%. In contrast, returns for the month were close to flat, and the past 3 months reflect a decline of about 12%. See our latest analysis for Universal Health Services. Universal...
NasdaqGS:MNDY
NasdaqGS:MNDYSoftware

How Investors May Respond To monday.com (MNDY) Rapid ARR Gains And Efficient Customer Payback Period

In the past quarter, monday.com reported annual recurring revenue of US$1.34 billion alongside gross margins near 89%, underscoring robust demand for its cloud-based work management platform. An interesting angle is the company’s roughly 30-month payback period on customer acquisition costs, which highlights how efficiently it converts marketing spend into durable subscription revenue. Next, we’ll examine how this rapid ARR expansion and efficient customer acquisition influence monday.com’s...
NYSE:BIP
NYSE:BIPIntegrated Utilities

Is It Too Late To Consider Brookfield Infrastructure Partners (NYSE:BIP) After 35% One Year Rally?

If you are wondering whether Brookfield Infrastructure Partners is still good value at around US$38.94, the key question is how its current price lines up with what the underlying business might be worth. The unit price has been relatively firm recently, with a 6.3% move over the last 30 days and a 13.5% return year to date, while the 1 year return sits at 35.5% and the 5 year return at 39.8%. These moves sit against an ongoing stream of news about global infrastructure demand, financing...